These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37454721)

  • 21. Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry.
    González-Domínguez R; García A; García-Barrera T; Barbas C; Gómez-Ariza JL
    Electrophoresis; 2014 Dec; 35(23):3321-30. PubMed ID: 25136972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study.
    Costa AC; Joaquim HPG; Forlenza OV; Gattaz WF; Talib LL
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):483-488. PubMed ID: 31218445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic and central nervous system metabolic alterations in Alzheimer's disease.
    van der Velpen V; Teav T; Gallart-Ayala H; Mehl F; Konz I; Clark C; Oikonomidi A; Peyratout G; Henry H; Delorenzi M; Ivanisevic J; Popp J
    Alzheimers Res Ther; 2019 Nov; 11(1):93. PubMed ID: 31779690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
    Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
    J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying Hair Biomarker Candidates for Alzheimer's Disease Using Three High Resolution Mass Spectrometry-Based Untargeted Metabolomics Strategies.
    Chang CW; Hsu JY; Hsiao PZ; Chen YC; Liao PC
    J Am Soc Mass Spectrom; 2023 Apr; 34(4):550-561. PubMed ID: 36973238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic signatures and risk of sarcopenia in suburb-dwelling older individuals by LC-MS-based untargeted metabonomics.
    Han P; Chen X; Liang Z; Liu Y; Yu X; Song P; Zhao Y; Zhang H; Zhu S; Shi X; Guo Q
    Front Endocrinol (Lausanne); 2024; 15():1308841. PubMed ID: 38962681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites.
    Kalecký K; German DC; Montillo AA; Bottiglieri T
    J Alzheimers Dis; 2022; 86(4):1875-1895. PubMed ID: 35253754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Targeted Mass Spectrometry Approach to Identify Peripheral Changes in Metabolic Pathways of Patients with Alzheimer's Disease.
    Reveglia P; Paolillo C; Angiolillo A; Ferretti G; Angelico R; Sirabella R; Corso G; Matrone C; Di Costanzo A
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nontargeted Metabolomic Analysis of Plasma Metabolite Changes in Patients with Adolescent Idiopathic Scoliosis.
    Xiao L; Yang G; Zhang H; Liu J; Guo C; Sun Y
    Mediators Inflamm; 2021; 2021():5537811. PubMed ID: 34121924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of chemical isotope labeling LC-MS for tissue metabolomics and its application for brain and liver metabolome profiling in Alzheimer's disease mouse model.
    Wang X; Han W; Yang J; Westaway D; Li L
    Anal Chim Acta; 2019 Mar; 1050():95-104. PubMed ID: 30661596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward a predictive model of Alzheimer's disease progression using capillary electrophoresis-mass spectrometry metabolomics.
    Ibáñez C; Simó C; Martín-Álvarez PJ; Kivipelto M; Winblad B; Cedazo-Mínguez A; Cifuentes A
    Anal Chem; 2012 Oct; 84(20):8532-40. PubMed ID: 22967182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
    Gu Y; Zang P; Li J; Yan Y; Wang J
    Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
    Huan T; Tran T; Zheng J; Sapkota S; MacDonald SW; Camicioli R; Dixon RA; Li L
    J Alzheimers Dis; 2018; 65(4):1401-1416. PubMed ID: 30175979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and metabolomics approach based on UHPLC-MS to evaluate therapeutic effect of lignans from S. Chinensis in alzheimer's disease.
    Zhou Y; Wei M; Fan M; Liu Z; Wang A; Liu Y; Men L; Pi Z; Liu Z; Song F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jul; 1178():122859. PubMed ID: 34274605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Strategy for Untargeted Chiral Metabolomics using Liquid Chromatography-High Resolution Tandem Mass Spectrometry.
    Pandey R; Collins M; Lu X; Sweeney SR; Chiou J; Lodi A; Tiziani S
    Anal Chem; 2021 Apr; 93(14):5805-5814. PubMed ID: 33818082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolite profiling of Alzheimer's disease cerebrospinal fluid.
    Czech C; Berndt P; Busch K; Schmitz O; Wiemer J; Most V; Hampel H; Kastler J; Senn H
    PLoS One; 2012; 7(2):e31501. PubMed ID: 22359596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterising Alzheimer's disease through integrative NMR- and LC-MS-based metabolomics.
    Nielsen JE; Maltesen RG; Havelund JF; Færgeman NJ; Gotfredsen CH; Vestergård K; Kristensen SR; Pedersen S
    Metabol Open; 2021 Dec; 12():100125. PubMed ID: 34622190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.
    Paglia G; Stocchero M; Cacciatore S; Lai S; Angel P; Alam MT; Keller M; Ralser M; Astarita G
    J Proteome Res; 2016 Feb; 15(2):608-18. PubMed ID: 26717242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in LC-MS-based metabolomics for Alzheimer's disease early detection: targeted approaches versus untargeted approaches.
    Reveglia P; Paolillo C; Ferretti G; De Carlo A; Angiolillo A; Nasso R; Caputo M; Matrone C; Di Costanzo A; Corso G
    Metabolomics; 2021 Aug; 17(9):78. PubMed ID: 34453619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Untargeted Metabolomics Analysis of the Serum Metabolic Signature of Childhood Obesity.
    Szczerbinski L; Wojciechowska G; Olichwier A; Taylor MA; Puchta U; Konopka P; Paszko A; Citko A; Goscik J; Fiehn O; Fan S; Wasilewska A; Taranta-Janusz K; Kretowski A
    Nutrients; 2022 Jan; 14(1):. PubMed ID: 35011090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.